Robert Ward, Chief Executive Officer at Eloxx Pharmaceuticals, Inc. (ELOX), bought 10,000 shares at $8.99 ($90K) on 2018-03-23, disclosed to the SEC on 2018-03-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |